Cytologidiagnoser enligt den nationella nomenklaturen per prov år 2022
|
Screening cytology |
Reflex cytology (Screening
HPV) |
Indicerad cytology |
||||||
|
(Reflex HPV) |
||||||||
|
SNOMED |
Number |
Percent |
Number |
Percent |
Number |
Percent |
||
|
Not assessable |
M09010 |
1 232 |
1,9% |
522 |
1.2% |
3 007 |
2.7% |
|
|
Missing endocervical cells |
M09019 |
3 909 |
6.0% |
3 213 |
7.6% |
11 435 |
10.4% |
|
|
Normal/ benign samples |
M00110 |
56 784 |
87.3% |
24 010 |
57.2% |
88 593 |
79.7% |
|
|
Atypical squamous cells of unknown origin (ASC-US) |
M69710 |
4 367 |
6.7% |
10 669 |
25.4% |
13 885 |
12.3% |
|
|
Suspected high-grade dysplasia (ASC-H) |
M69719 |
293 |
0.5% |
1 200 |
2.9% |
1 777 |
1.6% |
|
|
low-grade squamous intraepithelial lesions (ASC-US) |
2 124 |
3.3% |
6 172 |
14.7% |
9 284 |
8.1% |
||
|
High-grade squamous intraepithelial lesions / HSIL |
329 |
0.5% |
1 721 |
4.1% |
2 156 |
1.9% |
||
|
Suspicion of squamous cancer |
4 |
<0.01% |
28 |
0.07% |
66 |
0.06% |
||
|
Atypical glandular cells (AGC) |
M69720 |
28 |
0.04% |
292 |
0.70% |
518 |
0.47% |
|
|
Adenocarcinoma in situ (AIS) or suspicion of Adenocarcinoma
(ASC-US) |
1 |
<0.01% |
55 |
0.13% |
135 |
0.12% |
||
|
Atypia in cells of unclear/ other cell type |
M69700 |
17 |
0.03% |
108 |
0.26% |
123 |
0.11% |
|
|
Malignant cells of unclear cell type/ other cell type |
M80009 |
0 |
0.00% |
1 |
<0.01% |
18 |
0.02% |
|
|
Non-interpretable |
57 |
0.09% |
3 |
<0.01% |
30 |
0.03% |
||
|
Number of samples |
|
65 010 |
|
42 001 |
|
111 770 |
|
|
1 M74006 (CIN1) was assigned to M80770
(LSIL); 2 M74007 (CIN2) and M80702 (CIN3) was assigned to M80772 (HSIL);
3 M80703 was assigned to M80701 (suspicion
about squamous cell carcinoma)); 4 M81403 (Adenocarcinoma) was assigned to
M81401 (suspicion about
Adenocarcinoma)